These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3651625)

  • 1. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
    Gonçalves E; Castro JA; Gross JL
    Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
    Kabadi U; Cech R
    Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
    Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmunization and multinodular large toxic goiter therapy using repeated doses of 131I].
    Pisarek M; Baczyk M; Gryczyńska M; Pietz L; Ziemnicka K; Sowiński J
    Pol Arch Med Wewn; 2006 Jun; 115(6):545-50. PubMed ID: 17263226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy for multinodular toxic goiter.
    Nygaard B; Hegedüs L; Ulriksen P; Nielsen KG; Hansen JM
    Arch Intern Med; 1999 Jun; 159(12):1364-8. PubMed ID: 10386513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term effect of 131I therapy of multinodular non-toxic goiter].
    Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE
    Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.
    Lewis A; Atkinson B; Bell P; Courtney H; McCance D; Mullan K; Hunter S
    Ulster Med J; 2013 May; 82(2):85-8. PubMed ID: 24082285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm.
    Schiavo M; Bagnara MC; Camerieri L; Pomposelli E; Giusti M; Pesce G; Reitano C; Caputo M; Bagnasco M
    Endocrine; 2015 Apr; 48(3):902-8. PubMed ID: 25151403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chorea associated with thyrotoxicosis due to toxic multinodular goiter.
    Masannat Y; Gandhy R; Olajide O; Kheetan R; Yaqub A
    Thyroid; 2011 Nov; 21(11):1279-80. PubMed ID: 21936672
    [No Abstract]   [Full Text] [Related]  

  • 19. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with toxic multinodular goiter.
    Erickson D; Gharib H; Li H; van Heerden JA
    Thyroid; 1998 Apr; 8(4):277-82. PubMed ID: 9588491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.